Older-onset hereditary breast and ovarian cancer (HBOC) syndrome patients and clinical value of germline multigene testing.

3 May, 2025

Older-onset hereditary breast and ovarian cancer (HBOC) syndrome patients and clinical value of germline multigene testing.

Rodoniki Iosifidou, Dimitrios Matthaios, Dimitrios George Petrakis, Eleftherios Kampletsas, Kevisa Potska, Christina Dogka, Anastasia Katseli, Georgios Tsaousis,
Dimitra Stefanou, Dimitrios Mavroudis, Avraam Assi, Vasiliki Michalaki, Maria Paraskeva, Elli Tripodaki, Evangelia Moirogiorgou, Hasan Senol Coskun, Gokhan Karakaya,
Evgenia Bleka, Angeliki Meintani, George Nasioulas

Search

Older-onset hereditary breast and ovarian cancer (HBOC) syndrome patients and clinical value of germline multigene testing.